# FDA Inspection 1172316 - Samir Arora - May 27, 2022

Source: https://www.keypedia.com/records/fda_inspections/samir-arora/026a8bd8-4918-4fea-a082-566b5da6e71b
Source feed: FDA_Inspections

> FDA Inspection 1172316 for Samir Arora on May 27, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1172316
- Company Name: Samir Arora
- Inspection Date: 2022-05-27
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1172316 - 2022-05-27](https://www.keypedia.com/records/fda_inspections/samir-arora/d2285973-ddf7-433f-8564-c96f87384528)
- [FDA Inspection 984858 - 2016-09-09](https://www.keypedia.com/records/fda_inspections/samir-arora/0126d450-a850-4d3a-a757-990f9f211c66)

Company: https://www.keypedia.com/companies/samir-arora/3005df86-41b6-4954-bd2d-665bcdb2badf

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d